Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5207315
Max Phase: Preclinical
Molecular Formula: C46H55ClFN9O7
Molecular Weight: 900.45
Associated Items:
ID: ALA5207315
Max Phase: Preclinical
Molecular Formula: C46H55ClFN9O7
Molecular Weight: 900.45
Associated Items:
Canonical SMILES: COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCN(CCC(=O)NCCCCCCCCNc2ccc3c(c2)C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1
Standard InChI: InChI=1S/C46H55ClFN9O7/c1-63-39-28-37-34(43(52-29-51-37)53-31-10-12-36(48)35(47)26-31)27-40(39)64-24-8-18-55-20-22-56(23-21-55)19-15-41(58)50-17-7-5-3-2-4-6-16-49-30-9-11-32-33(25-30)46(62)57(45(32)61)38-13-14-42(59)54-44(38)60/h9-12,25-29,38,49H,2-8,13-24H2,1H3,(H,50,58)(H,51,52,53)(H,54,59,60)
Standard InChI Key: UCLWPMAGPRUQED-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 900.45 | Molecular Weight (Monoisotopic): 899.3897 | AlogP: 5.92 | #Rotatable Bonds: 22 |
Polar Surface Area: 187.43 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 8.06 | CX LogP: 4.62 | CX LogD: 3.87 |
Aromatic Rings: 4 | Heavy Atoms: 64 | QED Weighted: 0.05 | Np Likeness Score: -1.07 |
1. Yu X, Cheng M, Lu K, Shen Y, Zhong Y, Liu J, Xiong Y, Jin J.. (2022) Exploring Degradation of Mutant and Wild-Type Epidermal Growth Factor Receptors Induced by Proteolysis-Targeting Chimeras., 65 (12.0): [PMID:35675209] [10.1021/acs.jmedchem.2c00345] |
Source(1):